Insider Buying: DIAGNOS (CVE:ADK) Director Purchases C$60,000.00 in Stock

DIAGNOS Inc. (CVE:ADK) Director Robert Dunn bought 200,000 shares of the stock in a transaction on Wednesday, July 29th. The stock was purchased at an average cost of C$0.30 per share, with a total value of C$60,000.00. Following the completion of the purchase, the director directly owned 2,117,778 shares in the company, valued at C$635,333.40. This trade represents a 10.43% increase in their position.

DIAGNOS Stock Performance

Shares of ADK opened at C$0.28 on Monday. DIAGNOS Inc. has a fifty-two week low of C$0.17 and a fifty-two week high of C$0.41. The company has a market capitalization of C$33.11 million, a PE ratio of -6.88 and a beta of -0.12. The stock has a fifty day moving average of C$0.24 and a two-hundred day moving average of C$0.26. The company has a debt-to-equity ratio of 204.05, a quick ratio of 0.68 and a current ratio of 1.49.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.